NCT06780475招募中不适用
Validation of in Vitro Method for Anti-MCPyV Immunotherapy on Patients With Merkel Cell Carcinoma of Skin
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 15
- 试验地点
- 1
- 主要终点
- Anti-MCPyV functionality
研究概览
简要总结
The aim of the study is to test and validate in vitro a cell therapy approach for MCPyV+ Merkel Cell Carcinoma patients.
详细描述
The aim of the study is to test and validate in vitro a cell therapy approach for MCPyV+ Merkel Cell Carcinoma patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients >= 18 years old;
- •Diagnosed with Merkel cell carcinoma of skin, ongoing for local treatment, systemic treatment, complementary treatment or an active follow-up;
- •Informed for the study and no-opposed for participation;
- •Affiliated with a social security scheme or in an equivalent situation.
排除标准
- •Patients ongoing another interventional clinical trial;
- •Patients under guardianship or trusteeship;
- •Pregnancy or breastfeed;
- •Patients refusal.
结局指标
主要结局
Anti-MCPyV functionality
时间窗: Day 0 and Day 4
Anti-MCPyV functionality, including cytotoxicity, of T cells obtained after in vitro culture.
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Cell-Mediated Immunity Based Primary Prophylaxis for CMV Infection in Organ Transplant RecipientsCytomegalovirus ViraemiaNCT02784756University Health Network, Toronto134
已完成
不适用
Cell Mediated Immunity for Secondary Prophylaxis in CMV SOT PatientsCytomegalovirus ViraemiaNCT02370758University Health Network, Toronto32
招募中
2 期
CMV Immunity Monitoring in Lung Transplant RecipientsLung Transplant ComplicationsNCT05708755NYU Langone Health50
撤回
3 期
Efficacy of BACMUNE (MV130) in the Prevention of Disease Due to COVID-19 Infection in Healthcare PersonnelCovid19NCT04452643Inmunotek S.L.
终止
1 期
A Study Using Allogenic-Cytomegalovirus (CMV) Specific Cells for Glioblastoma Multiforme (GBM)Glioblastoma MultiformeNCT00990496Milton S. Hershey Medical Center25